Collegium Pharmaceutical, Inc. (COLL) Return on equity 2016–2025
Collegium Pharmaceutical, Inc. (COLL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
20.8%FY2025 · since FY2016: -69.8% → 20.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 20.8% | -9.4 pp |
| FY2024 | 30.2% | +5.6 pp |
| FY2023 | 24.6% | +37.5 pp |
| FY2022 | -12.8% | -48.1 pp |
| FY2021 | 35.2% | +20.9 pp |
| FY2020 | 14.4% | +40.4 pp |
| FY2019 | -26.0% | +16.7 pp |
| FY2018 | -42.7% | +29.2 pp |
| FY2017 | -71.9% | -2.1 pp |
| FY2016 | -69.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice